# Palliative Radiotherapy to Dominant Symptomatic Lesion in Patients With Hormone Refractory Prostate Cancer

> **NCT03658434** · NA · UNKNOWN · sponsor: **Zealand University Hospital** · enrollment: 34 (estimated)

## Conditions studied

- Hormone-refractory Prostate Cancer

## Interventions

- **RADIATION:** Palliative radiotherapy

## Key facts

- **NCT ID:** NCT03658434
- **Lead sponsor:** Zealand University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-01
- **Primary completion:** 2019-08-01
- **Final completion:** 2020-08-01
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2018-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03658434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03658434, "Palliative Radiotherapy to Dominant Symptomatic Lesion in Patients With Hormone Refractory Prostate Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03658434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*